Moderna COVID Vaccine Sales Forecasts Fall Short For 2022, 2023 0 03.11.2022 17:54 International Business Times Moderna Inc on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023 outlook for the shots well below Wall Street estimates, sending its shares down as much as 9%. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
